This topic contains a solution. Click here to go to the answer
« previous next »

Author Question: Which slow-acting neurotransmitter will be released in a patient experiencing signs and symptoms of ... (Read 80 times)

vinney12

  • Hero Member
  • *****
  • Posts: 586
on: Jul 23, 2018
Which slow-acting neurotransmitter will be released in a patient experiencing signs and symptoms of shock?
 
  A) Dopamine
  B) Norepinephrine
  C) Serotonin
  D) Antidiuretic hormone

Question 2

A patient is admitted to the surgical division after a mastectomy. The patient has a PCA pump and states to you that she is fearful she will overdose on morphine. Which of the following interventions is most appropriate to teach the patient?
 
  A) The pump will administer all of the doses, so you don't have to worry.
  B) If you follow the instructions, that won't happen to you.
  C) The device is preset, so you cannot receive more than you need.
  D) The device will give you a placebo when you press it often.


Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

CourtneyCNorton

  • Sr. Member
  • ****
  • Posts: 317
Reply #1 on: Jul 23, 2018
Answer to Question 1

D

Answer to Question 2

C


vinney12

  • Member
  • Posts: 586
Reply 2 on: Jul 23, 2018
Excellent

kthug

  • Member
  • Posts: 332
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

« previous next »
 

Did you know?

Warfarin was developed as a consequence of the study of a strange bleeding disorder that suddenly occurred in cattle on the northern prairies of the United States in the early 1900s.

Did you know?

Sperm cells are so tiny that 400 to 500 million (400,000,000–500,000,000) of them fit onto 1 tsp.

Did you know?

More than 50% of American adults have oral herpes, which is commonly known as "cold sores" or "fever blisters." The herpes virus can be active on the skin surface without showing any signs or causing any symptoms.

Did you know?

The FDA recognizes 118 routes of administration.

Did you know?

Stevens-Johnson syndrome and Toxic Epidermal Necrolysis syndrome are life-threatening reactions that can result in death. Complications include permanent blindness, dry-eye syndrome, lung damage, photophobia, asthma, chronic obstructive pulmonary disease, permanent loss of nail beds, scarring of mucous membranes, arthritis, and chronic fatigue syndrome. Many patients' pores scar shut, causing them to retain heat.

Patient receiving ultrasound treatment to the left elbow. Patient receiving ultrasound treatment to the left elbow.
Localization of a Peptide The peptide is revealed by means of immunocytochemistry. The photomicrogra Localization of a Peptide The peptide is revealed by means of immunocytochemistry. The photomicrogra
The approval of a new drug is a four-stage process: (1) preclinical investigation, (2) clinical inve The approval of a new drug is a four-stage process: (1) preclinical investigation, (2) clinical inve
Patient Teaching Methods Cont. Patient Teaching Methods Cont.
Examples of endocrine disorders. (A) A patient with exophthalmos, a symptom of hyperthyroidism ... Examples of endocrine disorders. (A) A patient with exophthalmos, a symptom of hyperthyroidism ...
Tumor marker analysis of a patient undergoing therapy, who (1) after surgery had residual disease ... Tumor marker analysis of a patient undergoing therapy, who (1) after surgery had residual disease ...
Video: Summary of female reproductive cycle days 1-28

For a complete list of videos, visit our video library